W-D Ludwig

1.0k total citations
13 papers, 756 citations indexed

About

W-D Ludwig is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, W-D Ludwig has authored 13 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 6 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in W-D Ludwig's work include Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Cell death mechanisms and regulation (3 papers). W-D Ludwig is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Cell death mechanisms and regulation (3 papers). W-D Ludwig collaborates with scholars based in Germany, Netherlands and China. W-D Ludwig's co-authors include Bernd Dörken, Christian Wuchter, Leonid Karawajew, V Ruppert, Richard Ratei, Claudia Schoch, Zhen Cai, Isrid Sturm, G. Henze and Aram Prokop and has published in prestigious journals such as Blood, Leukemia and PubMed.

In The Last Decade

W-D Ludwig

13 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W-D Ludwig Germany	13	397	278	213	190	149	13	756
Carla Mazzone Italy	15	479 1.2×	576 2.1×	191 0.9×	183 1.0×	219 1.5×	47	951
C. Vasselon France	11	625 1.6×	420 1.5×	113 0.5×	273 1.4×	139 0.9×	27	964
Victoria Grandage United Kingdom	9	492 1.2×	472 1.7×	264 1.2×	177 0.9×	147 1.0×	16	926
Gianfranco Catalano Italy	13	380 1.0×	512 1.8×	168 0.8×	93 0.5×	105 0.7×	44	867
MR Grever United States	12	299 0.8×	188 0.7×	165 0.8×	208 1.1×	389 2.6×	24	848
N. Roubi France	6	558 1.4×	377 1.4×	83 0.4×	232 1.2×	116 0.8×	8	809
Toshiya Yokozawa Japan	8	281 0.7×	222 0.8×	108 0.5×	100 0.5×	107 0.7×	17	528
Marina Lanciotti Italy	17	267 0.7×	160 0.6×	84 0.4×	129 0.7×	68 0.5×	51	733
R. Pelka‐Fleischer Germany	15	277 0.7×	206 0.7×	62 0.3×	279 1.5×	59 0.4×	27	653
Paola Panetta Italy	14	440 1.1×	573 2.1×	234 1.1×	145 0.8×	162 1.1×	27	858

Countries citing papers authored by W-D Ludwig

Since Specialization

Citations

This map shows the geographic impact of W-D Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W-D Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W-D Ludwig more than expected).

Fields of papers citing papers by W-D Ludwig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W-D Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W-D Ludwig. The network helps show where W-D Ludwig may publish in the future.

Co-authorship network of co-authors of W-D Ludwig

This figure shows the co-authorship network connecting the top 25 collaborators of W-D Ludwig. A scholar is included among the top collaborators of W-D Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W-D Ludwig. W-D Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kox, Corinne, M Zimmermann, Martin Stanulla, et al.. (2010). The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL–BFM 2000 protocol can be separated from FBXW7 loss of function. Leukemia. 24(12). 2005–2013. 95 indexed citations

Buske, Christian, Eva Hoster, Martin Dreyling, et al.. (2008). The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG). Leukemia. 23(1). 153–161. 99 indexed citations

Rhein, Peter, Stefanie Scheid, Richard Ratei, et al.. (2007). Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia. Leukemia. 21(5). 897–905. 29 indexed citations

Ratei, Richard, Leonid Karawajew, Francis Lacombe, et al.. (2007). Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping. Leukemia. 21(6). 1204–1211. 19 indexed citations

Wuchter, Christian, Daniel Krappmann, Zhen Cai, et al.. (2001). In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-κB activity. Leukemia. 15(6). 921–928. 63 indexed citations

Cai, Zhen, Christian Wuchter, V Ruppert, et al.. (2001). Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation. Leukemia. 15(4). 567–574. 52 indexed citations

Wuchter, Christian, Richard Ratei, Günther Spahn, et al.. (2001). Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.. PubMed. 86(2). 154–61. 50 indexed citations

Prokop, Aram, Thomas Wieder, Isrid Sturm, et al.. (2000). Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo. Leukemia. 14(9). 1606–1613. 140 indexed citations

Wuchter, Christian, Jochen Harbott, Claudia Schoch, et al.. (2000). Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1. Leukemia. 14(7). 1232–1238. 51 indexed citations

10.

Wuchter, Christian, Leonid Karawajew, V Ruppert, et al.. (1999). Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics. Leukemia. 13(12). 1943–1953. 65 indexed citations

11.

Rieder, Harald, J. Mäurer, Stefan Schwartz, et al.. (1998). High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia. Leukemia. 12(9). 1473–1481. 29 indexed citations

12.

Hj, Bühring, I Sures, Bahija Jallal, et al.. (1995). The receptor tyrosine kinase p185HER2 is expressed on a subset of B- lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia. Blood. 86(5). 1916–1923. 34 indexed citations

13.

Mapara, MY, Kurt Bommert, Chao Leng, et al.. (1995). G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation. Blood. 85(7). 1836–1842. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact